Spinal muscular atrophy—insights and challenges in the treatment era

E Mercuri, MC Pera, M Scoto, R Finkel… - Nature Reviews …, 2020 - nature.com
Spinal muscular atrophy (SMA) is an autosomal recessive motor neuron disease caused by
deletion or mutation of SMN1. Four subtypes exist, characterized by different clinical …

Molecular biomarkers and cognitive impairment in multiple sclerosis: state of the field, limitations, and future direction–a systematic review and meta-analysis

TD Rademacher, SG Meuth, H Wiendl, A Johnen… - Neuroscience & …, 2023 - Elsevier
Objective Multiple sclerosis (MS) is associated with cognitive impairment (CI) such as
slowed information processing speed (IPS). Currently, no immunocellular or molecular …

Peripheral blood and salivary biomarkers of blood–brain barrier permeability and neuronal damage: clinical and applied concepts

D Janigro, DM Bailey, S Lehmann, J Badaut… - Frontiers in …, 2021 - frontiersin.org
Within the neurovascular unit (NVU), the blood–brain barrier (BBB) operates as a key
cerebrovascular interface, dynamically insulating the brain parenchyma from peripheral …

Velusetrag rescues GI dysfunction, gut inflammation and dysbiosis in a mouse model of Parkinson's disease

J Grigoletto, F Miraglia, L Benvenuti… - npj Parkinson's …, 2023 - nature.com
In patients with Parkinson's disease (PD), constipation is common, and it appears in a
prodromal stage before the hallmark motor symptoms. The present study aimed to …

Haematopoietic stem cell transplantation for the treatment of multiple sclerosis: Recent advances

A Mariottini, E De Matteis, MT Cencioni… - Current Neurology and …, 2023 - Springer
Abstract Purpose of Review Autologous haematopoietic stem cell transplantation (AHSCT)
is increasingly considered a treatment option for patients with multiple sclerosis (MS), an …

The evolving role of extracellular vesicles (exosomes) as biomarkers in traumatic brain injury: Clinical perspectives and therapeutic implications

NA Khan, M Asim, A El-Menyar, KH Biswas… - Frontiers in Aging …, 2022 - frontiersin.org
Developing effective disease-modifying therapies for neurodegenerative diseases (NDs)
requires reliable diagnostic, disease activity, and progression indicators. While desirable …

Enjoy carefully: the multifaceted role of vitamin E in neuro-nutrition

L Regner-Nelke, C Nelke, CB Schroeter… - International Journal of …, 2021 - mdpi.com
Vitamin E is often associated with health benefits, such as antioxidant, anti-inflammatory and
cholesterol-lowering effects. These properties make its supplementation a suitable …

Intermediate filaments associate with aggresome-like structures in proteostressed C. elegans neurons and influence large vesicle extrusions as exophers

ML Arnold, J Cooper, R Androwski, S Ardeshna… - Nature …, 2023 - nature.com
Toxic protein aggregates can spread among neurons to promote human neurodegenerative
disease pathology. We found that in C. elegans touch neurons intermediate filament …

Circulating biomarkers in neuromuscular disorders: what is known, what is new

A Barp, A Ferrero, S Casagrande, R Morini… - Biomolecules, 2021 - mdpi.com
The urgent need for new therapies for some devastating neuromuscular diseases (NMDs),
such as Duchenne muscular dystrophy or amyotrophic lateral sclerosis, has led to an …

Emerging Trends: Neurofilament Biomarkers in Precision Neurology

P Sharma, A Giri, PN Tripathi - Neurochemical Research, 2024 - Springer
Neurofilaments are structural proteins found in the cytoplasm of neurons, particularly in
axons, providing structural support and stability to the axon. They consist of multiple …